GGrantIndex
Sort

326,823 grants matching clinical trial

Pathobiology and treatment of patients with inborn errors of immunity

$2,137,125
Sung-Yun Pai · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

BIOLOGICAL MARKERS OF BREAST CANCER &TAMOXIFEN RESPONSE

$2,137,040
University Of Pennsylvania · P01 · FY2003 · CA

PRISM LICENSES, HOSTING AND MAINTENANCE

$2,137,014
Matt Nace · · N02 · FY2023 · HL

SPORE in Lung Cancer

$2,136,998
Paul A Bunn · University Of Colorado Denver · P50 · FY2007 · CA

Aging Intervention Studies

$2,136,884
Julie Mattison · National Institute On Aging · ZIA · FY2021 · AG

University of North Carolina AIDS Clinical Trials Unit (UNC ACTU)

$2,136,814
Joseph J. Eron · Univ Of North Carolina Chapel Hill · U01 · FY2007 · AI

MECHANISMS AND MODULATION OF ACCELLULAR HbA TOXICITY

$2,136,665
Joel M Friedman · Albert Einstein College Of Medicine, Inc · P01 · FY2016 · HL

Emergency Care Redesign (ECR)

$2,136,433
Joshua Chodosh · New York University School Of Medicine · U19 · FY2024 · AG

SPORE in Soft Tissue Sarcoma

$2,136,282
Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2013 · CA

Specialized Program of Research Excellence in Myeloma

$2,136,145
Kenneth C Anderson · Dana-Farber Cancer Inst · P50 · FY2007 · CA

The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)

$2,136,131
Charles W. Flexner · Johns Hopkins University · UM1 · FY2018 · AI

Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents

$2,136,000
Scott M Lippman · University Of Tx Md Anderson Can Ctr · N01 · FY2009 · CA

PROSTATE CANCER CLINICAL TRIALS CONSORTIUM: DANA-FARBER

$2,136,000
Dana-Farber Cancer Institute, Inc. · · FY2022 · Defense Health Agency

Biology and Therapy of High Risk Neuroblastoma

$2,135,965
Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2010 · CA

Biology & Transplantation of the Human Stem Cell

$2,135,909
Philip McGlave · University Of Minnesota · P01 · FY2009 · CA

SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer

$2,135,538
Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2015 · CA

Anti-HIV Gene Therapy: Defend and Attack

$2,135,528
Irvin S.y. Chen · University Of California Los Angeles · U19 · FY2017 · AI

Development And Production Of Filovirus DNA Plasmid Vaccines

$2,135,478
Kimberly Wallace · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

New York Columbia Collaborative SPOTRIAS

$2,135,332
Randolph S Marshall · Columbia University Health Sciences · P50 · FY2013 · NS

Reproductive Endocrinology And Infertility Clinical Training Program

$2,135,324
James H. Segars · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIE · FY2011 · HD

Epitope-targeted Vaccines for HIV-1 Prevention

$2,135,189
Xiangpeng Kong · New York University School Of Medicine · P01 · FY2014 · AI

Administrative Core

$2,135,132
Jose A Torres-Ruiz · Ponce School Of Medicine · U54 · FY2025 · MD

Stroke Disparities Program

$2,135,011
Chelsea M Kidwell · Georgetown University · U54 · FY2007 · NS

Cancer Therapy & Research Center at UTHSCSA

$2,135,000
Ruben A Mesa · University Of Texas Hlth Science Center · P30 · FY2019 · CA

University of Florida Health Cancer Center Support Grant

$2,134,999
Jonathan D. Licht · University Of Florida · P30 · FY2023 · CA